Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator

Clinical trial NCT06233240 · UNKNOWN

Trial details

NCT number: NCT06233240
Sponsor: Bio-innova Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-04-30
Primary completion: 2024-05-29
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.